RACHEL TROIAN: Open Payments
NPI 1578155180 · DAYTONA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,271 in 149 payments from 47 companies in 2025. Trend: 2023 $4,577 · 2024 $4,472 · 2025 $4,271
Food & beverage: $4,103Education: $168
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $418 |
| Janssen Biotech, Inc. | 15 | $355 |
| Incyte Corporation | 3 | $262 |
| Daiichi Sankyo Inc. | 12 | $261 |
| Astellas Pharma US Inc | 6 | $252 |
| Regeneron Healthcare Solutions, Inc. | 6 | $238 |
| Merck Sharp & Dohme LLC | 9 | $224 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $214 |
| Geron Corporation | 5 | $195 |
| BeOne Medicines USA, Inc. | 4 | $192 |
Products named: Enhertu, JAKAFI, KEYTRUDA, RYBREVANT, LIBTAYO, Nubeqa, RYTELO, BRUKINSA.
Industry payments across FL — which companies pay providers there.
